So in your opinion, Plotinus, what is the primary
Post# of 157598

Quote:
So in your opinion, Plotinus, what is the primary reason for slow CRC enrollment? I know we saw the same thing with all those hospitals in Brazil (was it 22?) that, even after months, had only enrolled a few patients.
In the Covid trials there was massive competition between drug trials for patients. There may be some of that in our CRC trial. Right after we had results from the mTNBC trials a family member asked if leronlimab would work for her friend's pancreatic cancer. I gave him all the information on CCR5 in cancer and the results from our studies and trials. I told him to have his doctor contact Cytodyn and get our drug under Right to Try or EIND. Instead his doctor enrolled him in a clinical trial in Houston. That trial failed miserably for him and he died within 6 months.

